Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Exploring the benefits and risks of owner-financing in real estate transactions.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Pat founded The Practical Planner, LLC in 1999.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Charting the Course: Navigating Towards Sustainable Futures - Insights from the 2023 Sustainability Panel | Jean-Louis Servranckx - President and CEO of Aecon Group Inc
00:10:00
Understanding Market Dynamics: A Conversation with Howard Marks | Howard Marks, Co-Founder , Oaktree Capital Management.
00:10:00
BAFS Q4/2008 Performance Highlight at SET Opportunity Day | M.R. Supadis Diskul - Director of Bangkok Aviation Fuel
00:10:00
Zenith Minerals: Active Exploration Across Diverse Australian Projects
00:10:00
RingCentral CEO Vlad Shmunis discusses the company's new AI product launch.
00:10:00
Susan Friedman interviews Ciena CTO Steve Alexander on the future of network construction and management.
00:10:00
David Solomon, Goldman Sachs CEO, sits down with CNBC's David Faber for a wide ranging interview
00:10:00
Keys to Success: Innovation, Punctuality, and Leadership Insights for Business Growth|Roshan Rajadurai,Managing Director,Hayleys Plc
00:10:00
Sanlam's Commitment to Transformation and Community Development | Paul Hanratty, CEO , Sanlam Limited.
00:10:00
Air New Zealand CEO Greg Foran Discusses Government Bailout, Repatriation, and Staffing Challenges | Greg Foran, CEO, Air New Zealand .
00:10:00
Chaarat Gold Holdings: Expanding Gold Operations in Former Soviet Union, Positioned for Significant Growth
00:10:00
Critical Resources (ASX: CRR) Twilight Series Review (September 2023) | Alex Cheeseman, Managing Director of Critical Resources Limited